These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29633471)

  • 41. Small ubiquitin-related modifier 1 is involved in hepatocellular carcinoma progression via mediating p65 nuclear translocation.
    Liu J; Tao X; Zhang J; Wang P; Sha M; Ma Y; Geng X; Feng L; Shen Y; Yu Y; Wang S; Fang S; Shen Y
    Oncotarget; 2016 Apr; 7(16):22206-18. PubMed ID: 26993772
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Resident brain neural precursor cells develop age-dependent loss of therapeutic functions in Alzheimer's mice.
    Fainstein N; Dan-Goor N; Ben-Hur T
    Neurobiol Aging; 2018 Dec; 72():40-52. PubMed ID: 30205359
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma SUMO1 Protein is Elevated in Alzheimer's Disease.
    Cho SJ; Yun SM; Lee DH; Jo C; Ho Park M; Han C; Ho Koh Y
    J Alzheimers Dis; 2015; 47(3):639-43. PubMed ID: 26401699
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systematic determinations of SUMOylation activation intermediates and dynamics by a sensitive and quantitative FRET assay.
    Song Y; Liao J
    Mol Biosyst; 2012 Jun; 8(6):1723-9. PubMed ID: 22466055
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Critical SUMO1 Modification of LKB1 Regulates AMPK Activity during Energy Stress.
    Ritho J; Arold ST; Yeh ET
    Cell Rep; 2015 Aug; 12(5):734-42. PubMed ID: 26212320
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibiting SUMO1-mediated SUMOylation induces autophagy-mediated cancer cell death and reduces tumour cell invasion via RAC1.
    Lorente M; García-Casas A; Salvador N; Martínez-López A; Gabicagogeascoa E; Velasco G; López-Palomar L; Castillo-Lluva S
    J Cell Sci; 2019 Oct; 132(20):. PubMed ID: 31578236
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SUMO-1 conjugation blocks beta-amyloid-induced astrocyte reactivity.
    Hoppe JB; Rattray M; Tu H; Salbego CG; Cimarosti H
    Neurosci Lett; 2013 Jun; 546():51-6. PubMed ID: 23651519
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SUMO1 negatively regulates the transcriptional activity of EVI1 and significantly increases its co-localization with EVI1 after treatment with arsenic trioxide.
    Singh S; Pradhan AK; Chakraborty S
    Biochim Biophys Acta; 2013 Oct; 1833(10):2357-68. PubMed ID: 23770046
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
    Bi Oh S; Suh N; Kim I; Lee JY
    Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of endogenous SUMO1 accepter sites by mass spectrometry.
    Hsiao HH; Meulmeester E; Urlaub H
    Methods Mol Biol; 2012; 893():431-41. PubMed ID: 22665316
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SUMO1 attenuates stress-induced ROS generation by inhibiting NADPH oxidase 2.
    Kim HJ; Yun J; Lee J; Hong H; Jeong J; Kim E; Bae YS; Lee KJ
    Biochem Biophys Res Commun; 2011 Jul; 410(3):555-62. PubMed ID: 21683690
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology.
    Spangenberg EE; Lee RJ; Najafi AR; Rice RA; Elmore MR; Blurton-Jones M; West BL; Green KN
    Brain; 2016 Apr; 139(Pt 4):1265-81. PubMed ID: 26921617
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
    Paouri E; Tzara O; Zenelak S; Georgopoulos S
    J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The nucleoporin RanBP2 has SUMO1 E3 ligase activity.
    Pichler A; Gast A; Seeler JS; Dejean A; Melchior F
    Cell; 2002 Jan; 108(1):109-20. PubMed ID: 11792325
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of a novel posttranslational modification in polypyrimidine tract-binding proteins by SUMO1.
    Han W; Wang L; Yin B; Peng X
    BMB Rep; 2014 Apr; 47(4):233-8. PubMed ID: 24286314
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential effects of SUMO1 and SUMO3 on PKR activation and stability.
    Maarifi G; El Asmi F; Maroui MA; Dianoux L; Chelbi-Alix MK
    Sci Rep; 2018 Jan; 8(1):1277. PubMed ID: 29352251
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
    Devi L; Ohno M
    Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decreased SUMOylation of the retinoblastoma protein in keratinocytes during the pathogenesis of vitiligo.
    Zhou M; Lin F; Xu W; Jin R; Xu A
    Mol Med Rep; 2018 Sep; 18(3):3469-3475. PubMed ID: 30066925
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sumoylation enhances the activity of the TGF-β/SMAD and HIF-1 signaling pathways in keloids.
    Lin X; Wang Y; Jiang Y; Xu M; Pang Q; Sun J; Yu Y; Shen Z; Lei R; Xu J
    Life Sci; 2020 Aug; 255():117859. PubMed ID: 32474020
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
    Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
    Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.